LyondellBasell Industries NV
NYSE:LYB
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
|
LyondellBasell Industries NV
NYSE:LYB
|
UK |
|
Welltower Inc
NYSE:WELL
|
US |
|
PTC Therapeutics Inc
F:BH3
|
US |
|
MFE-MEDIAFOREUROPE NV
F:T0J1
|
IT |
|
Caixa Seguridade Participacoes SA
BOVESPA:CXSE3
|
BR |
|
N
|
Novozymes A/S
DUS:NZM2
|
DK |
|
Tech Mahindra Ltd
BSE:532755
|
IN |
|
I
|
Insight Enterprises Inc
XBER:IEI
|
US |
|
U
|
United Labels AG
DUS:ULC
|
DE |
|
C
|
Cyient DLM Ltd
BSE:543933
|
IN |
|
GlaxoSmithKline PLC
LSE:GSK
|
UK |
|
G
|
GlaxoSmithKline PLC
XBER:GS7
|
UK |
|
Valor Holdings Co Ltd
TSE:9956
|
JP |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
I
|
Ingersoll Rand Inc
SWB:5GD
|
US |
|
S
|
Smith & Wesson Brands Inc
F:SWS
|
US |
|
D
|
Deutsche Telekom AG
LSE:0MPH
|
DE |
Reverse DCF
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|